92 related articles for article (PubMed ID: 3342895)
1. Hypoprolactinemia and ovarian function.
Kauppila A; Martikainen H; Puistola U; Reinilä M; Rönnberg L
Fertil Steril; 1988 Mar; 49(3):437-41. PubMed ID: 3342895
[TBL] [Abstract][Full Text] [Related]
2. Human menopausal gonadotropin/human chorionic gonadotropin-induced ovarian hyperstimulation with transient hyperprolactinemia: steroidogenesis enhanced during bromocriptine therapy in monkeys.
Collins RL; Williams RF; Hodgen GD
J Clin Endocrinol Metab; 1984 Oct; 59(4):727-33. PubMed ID: 6434577
[TBL] [Abstract][Full Text] [Related]
3. Bromocriptine therapy of luteal insufficiency accompanied with hyperprolactinemia in the follicular phase.
Kano T; Nishikawa K
Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jul; 35(7):975-80. PubMed ID: 6875348
[TBL] [Abstract][Full Text] [Related]
4. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
5. Prolactin suppression by bromocriptine stimulates aromatization of testosterone to estradiol in women.
Martikainen H; Rönnberg L; Puistola U; Tapanainen J; Orava M; Kauppila A
Fertil Steril; 1989 Jul; 52(1):51-4. PubMed ID: 2744187
[TBL] [Abstract][Full Text] [Related]
6. Effect of drug-induced hyper- and hypoprolactinemia on human corpus luteum.
Garcea N; Campo S; Siccardi P; Panetta V; Venneri M; Dargenio R
Acta Eur Fertil; 1983; 14(1):35-40. PubMed ID: 6326451
[TBL] [Abstract][Full Text] [Related]
7. Follicular fluid treatment during the follicular versus luteal phase of the menstrual cycle: effects on corpus luteum function.
Stouffer RL; Hodgen GD; Ottobre AC; Christian CD
J Clin Endocrinol Metab; 1984 Jun; 58(6):1027-33. PubMed ID: 6427256
[TBL] [Abstract][Full Text] [Related]
8. Effects of metoclopramide-induced hyperprolactinemia during early follicular development on human ovarian function.
Kauppila A; Kirkinen P; Orava M; Vihko R
J Clin Endocrinol Metab; 1984 Nov; 59(5):875-81. PubMed ID: 6384260
[TBL] [Abstract][Full Text] [Related]
9. Peripheral and not central suppression of ovarian function during osmotic pump infusion of adrenocorticotropin-(1-24) for one menstrual cycle in the cynomolgus monkey and its partial compensation by a transitory elevation of sex hormone-binding globulin levels.
Kowalski W; Chatterton RT
Endocrinology; 1992 Jun; 130(6):3582-92. PubMed ID: 1597155
[TBL] [Abstract][Full Text] [Related]
10. [The role of prolactin during the estrus cycle of cattle].
Bevers MM; Dieleman SJ; Kruip TA
Tijdschr Diergeneeskd; 1988 Nov; 113(22):1227-36. PubMed ID: 2849816
[TBL] [Abstract][Full Text] [Related]
11. [Effect of serum prolactin levels on luteal function in patients with recurrent abortions].
Gu F
Zhonghua Fu Chan Ke Za Zhi; 1993 Jan; 28(1):34-7, 60. PubMed ID: 8504708
[TBL] [Abstract][Full Text] [Related]
12. [Antigonadotropic actions of prolactin. Study of 10 cases of women with hyperprolactinemia].
Schaison G; Mowszowicz I; Cesselin E; Lagoguey M
Nouv Presse Med; 1977 Feb; 6(6):425-8. PubMed ID: 320558
[TBL] [Abstract][Full Text] [Related]
13. [Luteal insufficiency as a prolactin-related disorder of the menstrual cycle].
Bohnet HG
Fortschr Med; 1980 Nov; 98(41):1618-23. PubMed ID: 6781997
[TBL] [Abstract][Full Text] [Related]
14. Delayed puberty induced by chronic suppression of prolactin release in the female rat.
Advis JP; White SS; Ojeda SR
Endocrinology; 1981 Nov; 109(5):1321-30. PubMed ID: 6271525
[TBL] [Abstract][Full Text] [Related]
15. Effects of subchronic infusion of dehydroepiandrosterone sulfate on serum gonadotropin levels and ovarian function in the cynomolgus monkey.
Kowalski W; Chatterton RT
Fertil Steril; 1992 Apr; 57(4):912-20. PubMed ID: 1532562
[TBL] [Abstract][Full Text] [Related]
16. Suppression of prolactin secretion during ovarian hyperstimulation is followed by elevated serum levels of endometrial protein PP14 in the late luteal phase.
Seppälä M; Martikainen H; Rönnberg L; Riittinen L; Kauppila A
Hum Reprod; 1989 May; 4(4):389-91. PubMed ID: 2745669
[TBL] [Abstract][Full Text] [Related]
17. Reduction of 5-day cycle length of female rats by treatment with bromocriptine.
van der Schoot P; Uilenbroek JT
J Endocrinol; 1983 Apr; 97(1):83-9. PubMed ID: 6682434
[TBL] [Abstract][Full Text] [Related]
18. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
[TBL] [Abstract][Full Text] [Related]
19. [The response of ovarian function to HMG-HCG and bromocriptine therapies in hyperprolactinemic patients].
Matsuoka M; Imura H; Aso T; Okuda K
Nihon Naibunpi Gakkai Zasshi; 1984 May; 60(5):647-58. PubMed ID: 6436078
[TBL] [Abstract][Full Text] [Related]
20. Follicular and luteal progesterone synergize to maintain 5-day cyclicity in rats.
Sánchez-Criado JE; Ruiz A; Tébar M; Mattheij JA
Rev Esp Fisiol; 1996 Dec; 52(4):223-9. PubMed ID: 9144843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
